Published in AIDS on July 06, 2001
A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing. Sci Transl Med (2012) 2.05
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials. J Antimicrob Chemother (2012) 1.54
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS (2012) 1.35
Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice. CMAJ (2003) 1.25
HIV, Hepatitis B, and Hepatitis C in Zambia. J Glob Infect Dis (2011) 1.22
Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem (2011) 1.18
Alcohol's role in HIV transmission and disease progression. Alcohol Res Health (2010) 1.17
Nevirapine induced Stevens-Johnson syndrome in an HIV infected patient. Indian J Pharmacol (2011) 1.07
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. Am J Med Sci (2007) 1.07
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clin Pharmacol (2012) 1.03
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. BMC Infect Dis (2005) 0.99
A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy. Br J Clin Pharmacol (2006) 0.99
The management of chronic viral hepatitis: A Canadian consensus conference 2004. Can J Infect Dis Med Microbiol (2004) 0.95
Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa. PLoS One (2010) 0.94
Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting. Afr Health Sci (2011) 0.92
Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test. PLoS One (2013) 0.90
Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication. PLoS One (2010) 0.86
Regional adipose tissue and elevations in serum aminotransferases in HIV-infected individuals. J Acquir Immune Defic Syndr (2008) 0.85
HIV viral suppression in the era of antiretroviral therapy. Postgrad Med J (2003) 0.84
Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century. Clin Liver Dis (2008) 0.83
Management of hepatitis B in patients coinfected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (2004) 0.81
Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study. BMC Infect Dis (2014) 0.80
A point-of-care paper-based fingerstick transaminase test: toward low-cost "lab-on-a-chip" technology for the developing world. Clin Gastroenterol Hepatol (2013) 0.80
The role of the immune system in nevirapine-induced subclinical liver injury of a rat model. ISRN Pharm (2012) 0.80
Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report. Ann Clin Microbiol Antimicrob (2002) 0.79
Antiretroviral Therapy-associated Serious and Life-threatening Toxicities. Curr Infect Dis Rep (2003) 0.78
Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature. BMC Infect Dis (2012) 0.78
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons. Clin Infect Dis (2015) 0.77
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART. PLoS One (2011) 0.77
Drug-induced Liver Injury. US Gastroenterol Hepatol Rev (2010) 0.76
Liver transplantation in HCV/HIV positive patients. World J Gastrointest Surg (2011) 0.76
Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment. Gastroenterol Hepatol (N Y) (2014) 0.75
Drug-Induced Liver Injury in HIV Patients. Gastroenterol Hepatol (N Y) (2006) 0.75
Evaluating the utility of early laboratory monitoring of antiretroviral-induced haematological and hepatic toxicity in HIV-infected persons in Cameroon. BMC Infect Dis (2014) 0.75
Proteomic analysis of serum and urine of HIV-monoinfected and HIV/HCV-coinfected patients undergoing long term treatment with nevirapine. Dis Markers (2014) 0.75
Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials. AIDS Res Treat (2014) 0.75
Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria. Ghana Med J (2014) 0.75
Severe cholestatic liver injury days after initiating antiretroviral therapy in a patient with AIDS: drug toxicity or immune reconstitution inflammatory syndrome? Dig Dis Sci (2005) 0.75
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Why do people sue doctors? A study of patients and relatives taking legal action. Lancet (1994) 10.79
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (2012) 10.61
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. N Engl J Med (1993) 4.88
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol (1992) 3.30
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis (1990) 2.83
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
[CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 2.56
Migration and geographic variations in blood pressure in Britain. BMJ (1990) 2.55
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med (1999) 2.55
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 2.37
Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet (2008) 2.37
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med (1996) 2.22
Cows' milk-sensitive enteropathy. Arch Dis Child (1978) 2.22
Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS (1996) 2.22
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis (2001) 2.19
Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J (1998) 2.13
Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med (1995) 2.07
A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol (1996) 2.05
Infertility among human immunodeficiency virus-positive women: incidence and treatment dilemmas. Hum Reprod (1996) 2.01
Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med (1998) 1.99
Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. AIDS Res Hum Retroviruses (2008) 1.98
Can ultrasound probes and coupling gel be a source of nosocomial infection in patients undergoing sonography? An in vivo and in vitro study. AJR Am J Roentgenol (1995) 1.97
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group. Lancet (1999) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis (1998) 1.86
The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol (1989) 1.84
Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature (1993) 1.82
The use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawals. Eur J Clin Pharmacol (2001) 1.79
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol (1987) 1.76
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS (1999) 1.73
Declaring independence: why we should be cautious. J Epidemiol Community Health (1990) 1.72
New rapid antigen test for diagnosis of pneumococcal meningitis. Lancet (2001) 1.70
Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis. J Clin Microbiol (1996) 1.70
Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS (1996) 1.64
Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest (1988) 1.64
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol (2006) 1.64
Do women with HIV infection consult with their GPs? Br J Gen Pract (1998) 1.62
The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. AIDS (1996) 1.60
Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology (1988) 1.59
Access to medical care one year prior to diagnosis in 100 HIV-positive women. Fam Pract (1997) 1.59
Purification and properties of Escherichia coli dihydrofolate reductase. Biochemistry (1975) 1.57
Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax (2009) 1.56
Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med (1982) 1.56
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet (2001) 1.55
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD. Am J Respir Crit Care Med (2000) 1.55
Assessing the cost-effectiveness of HAART for adults with HIV in England. HIV Med (2001) 1.55
Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med (2000) 1.51
Computer conferencing: the "nurse" in the "Electronic School District". Comput Nurs (1992) 1.51
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS. J Infect (1990) 1.50
Disease progression and survival in HIV-1-infected Africans in London. AIDS (1998) 1.47
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. Ann Intern Med (1995) 1.47
Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer (2000) 1.47
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS (2001) 1.46
The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol (1989) 1.46
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci U S A (2005) 1.45
Can the prevalence of disease risk factors be assessed from general practice records? Br Med J (Clin Res Ed) (1986) 1.45
Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol (2000) 1.44
Severe bacterial non-aids infections in HIV-positive persons: incidence rates and risk factors. J Infect (2013) 1.43
Measles immunisation rates and the good practice allowance. Br Med J (Clin Res Ed) (1986) 1.42
Serum proteins and mortality. Lancet (1990) 1.41
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ (1994) 1.41
[Cytokines value as a sepsis and mortality predictor in elderly patients with fever]. Med Clin (Barc) (2003) 1.40
[Usefulness of the somatostatin analog SMS 201-995 in the treatment of diarrhea in patients infected with the human immunodeficiency virus]. Med Clin (Barc) (1990) 1.40
[Placebo in drug clinical trials]. Med Clin (Barc) (1997) 1.40
[Varicella pneumonia in adults infected by HIV-1. Presentation of 2 cases]. Enferm Infecc Microbiol Clin (1994) 1.39